CURE Childhood Cancer Annual Report 2013-2014
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
n a m e d f u n d s<br />
The Strong, Steady Support of Named Funds.<br />
Named Funds offer a way for friends, family members, neighbors, colleagues and others to commemorate a<br />
child who has battled cancer or an individual who has demonstrated a dedication to the field of childhood<br />
cancer. In <strong>2013</strong>-<strong>2014</strong>, <strong>CURE</strong>’s Named Funds raised an astounding $632,610.<br />
Th e Ca r l o s S. A lva r a d o, M.D. P e d i at r ic Ca n c e r R e s e a rch F u n d<br />
This fund is named in honor of Dr. Carlos Alvarado, a dedicated pediatric oncologist who<br />
retired in 2009 after nearly three decades of service at Children’s Healthcare of Atlanta.<br />
Dr. Alvarado skillfully and compassionately cared for children with cancer while also<br />
contributing significantly to a search for a cure through his research efforts. The Carlos<br />
S. Alvarado, M.D. Pediatric Research Fund has continued his work into the future by<br />
funding lifesaving research at the Aflac <strong>Cancer</strong> and Blood Disorders Center of Children’s<br />
Healthcare of Atlanta.<br />
Th e Tr e n t o n W. K i n d r e d R e s e a rch F u n d<br />
This fund is named in honor of Trenton Kindred, diagnosed with stage IV neuroblastoma<br />
just after his first birthday. Trenton is a survivor, now 11, playing football and living life to<br />
the fullest, notwithstanding health challenges from the extensive treatment he received to<br />
save his life. Believing a cure for neuroblastoma is possible in our lifetime, the Kindred family<br />
is dedicated to furthering research for other children. In <strong>2013</strong>-<strong>2014</strong>, the Trenton Kindred<br />
Research Fund raised more than $43,000 to support neuroblastoma research spearheaded<br />
by Dr. Kelly Goldsmith at the Aflac <strong>Cancer</strong> and Blood Disorders Center of Children’s<br />
Healthcare of Atlanta.<br />
P r e s s On To Cure Ch i l d h o o d Ca n c e r<br />
The Press On Fund was formed in June 2006, by Stephen and Erin Chance after their threeyear-old<br />
son, Patrick, was diagnosed with stage IV neuroblastoma. Three years later, the<br />
Simkins family — lifelong friends of the Chances — had their own run-in with childhood<br />
cancer, when Brennan Simkins was diagnosed with acute myeloid leukemia (AML) on the<br />
eve of his 7th birthday. While the source of Brennan’s AML is a chromosomal abnormality,<br />
Brennan is at high risk for developing treatment-related AML. With both boys battling cancer,<br />
the Simkins and Chance families banded together and expanded the mission of the Press On<br />
Fund to include research for AML. Tragically but heroically, Patrick Chance passed away on his<br />
9th birthday — January 9, 2012. The Press On Fund provides grants to scientists conducting<br />
research aimed at developing novel, targeted therapies for neuroblastoma and AML. Through<br />
generous individual gifts and events, Press On raised $372,595 for novel neuroblastoma research<br />
at Memorial Sloan Kettering <strong>Cancer</strong> Center and St. Jude Children’s Research Hospital.<br />
22